Related Experiment Videos
p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas
Y Yatabe1, A Masuda, T Koshikawa
1Department of Pathology, Aichi Cancer Center Hospital, Nagoya, Japan.
Abstract:
Small cell lung cancers (SCLCs) and non-small cell lung cancers (NSCLCs), two major categories of human lung cancers, have been shown to exhibit considerably different clinicopathological, biological, and molecular genetic characteristics. Inactivation of cyclin-dependent kinase inhibitors is now thought to play an important part in the pathogenesis of this fatal disease. In the present study, we show that in vitro p27KIP1 expression was associated with cell density-dependent growth inhibition in human lung epithelial cells in vitro, whereas in vivo, p27KIP1 expression in lung cells showed an inverse correlation with proliferative activity in the developing and adult normal lungs. Our immunohistochemical examination of 166 lung tumor specimens also revealed a striking difference in p27KIP1 expression between SCLCs and NSCLCs. Of 149 NSCLCs, 107 (72%) showed reduced p27KIP1 expression, with 8 being virtually negative. Furthermore, p27KIP1 expression status was found to be a significant prognostic factor for patient survival in the analysis of the 149 primary, resected NSCLC cases (P = 0.03 by the log-rank test). In contrast, all SCLC specimens thus far examined exhibited significantly increased staining when compared to the corresponding normal lung epithelium. These findings provide additional evidence for the heterogeneity prevalent in human lung cancers and suggest that p27KIP1 might play distinct biological roles in the pathogenesis of the two major histological categories, warranting additional studies to elucidate the functional consequences of such differences.
Insights
Cyclin-dependent kinase inhibitor p27KIP1 expression differs significantly between small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Reduced p27KIP1 predicts poor survival in NSCLC, while SCLC shows increased expression, highlighting distinct roles in lung cancer pathogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) exhibit distinct clinicopathological and molecular features.
- Inactivation of cyclin-dependent kinase inhibitors is implicated in lung cancer development.
- The role of p27KIP1 in lung cancer pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the expression patterns of p27KIP1 in SCLC and NSCLC.
- To determine the correlation between p27KIP1 expression and clinicopathological features, including patient survival.
- To explore the differential roles of p27KIP1 in the two major lung cancer subtypes.
Main Methods:
- Immunohistochemical analysis of p27KIP1 expression in 166 human lung tumor specimens (149 NSCLCs and 17 SCLCs).
- Correlation analysis between p27KIP1 expression status and patient survival in NSCLC cases.
- Comparison of p27KIP1 expression in tumor tissues versus corresponding normal lung epithelium.
Main Results:
- p27KIP1 expression was associated with density-dependent growth inhibition in normal lung epithelial cells.
- Reduced p27KIP1 expression was observed in 72% of NSCLC cases (107/149), with 8% being nearly negative.
- Reduced p27KIP1 expression was a significant prognostic factor for patient survival in NSCLC (P = 0.03).
- All examined SCLC specimens showed significantly increased p27KIP1 staining compared to normal lung tissue.
Conclusions:
- p27KIP1 exhibits distinct expression patterns in SCLC and NSCLC, underscoring lung cancer heterogeneity.
- p27KIP1 may play different biological roles in the pathogenesis of SCLC and NSCLC.
- Further research is warranted to understand the functional implications of these differential p27KIP1 roles.